Jayson Rieger bought $126k of VRCA
CEO and President at Verrica Pharmaceuticals Inc.. 25,000 shares at an average of $5.03, traded Aug 14, 2026, filed Aug 18, 2026.
Score components
- +25RoleCEO
- +11Trade size$126k at market
- +3Relative to holdingsHoldings up 14%
- +8Price context45% below the 52-week high
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002043558-26-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | POpen-market purchase Common Stock | +20,000 | $5.06 | $101k | 202,593 | Aug 18, 2026 |
| Aug 17, 2026 | POpen-market purchase Common Stock | +5,000 | $4.91 | $25k | 207,593 | Aug 18, 2026 |
Related signals
Other insiders at Verrica Pharmaceuticals Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 51Moderate | Verrica Pharmaceuticals Inc. | John J. Kirby Interim CFO | $25k 5,000 shares | +26% | |
| 53Moderate | Verrica Pharmaceuticals Inc. | Noah L. Rosenberg CMO | $31k 6,230 shares | +264% | |
| 54Moderate | Verrica Pharmaceuticals Inc. | David Zawitz Chief Operating Officer | $30k 6,000 shares | +29% | |
| 55Moderate | Verrica Pharmaceuticals Inc. | John J. Kirby Interim CFO | $15k 3,536 shares | +65% | |
| 73Notable | Verrica Pharmaceuticals Inc. | Paul B Manning director, owner | $18M 4,126,142 shares | +160% | |
| 74Notable | Verrica Pharmaceuticals Inc. | Jayson Rieger CEO and President | $400k 94,311 shares | +107% | |
| 46Moderate | Verrica Pharmaceuticals Inc. | Noah L. Rosenberg CMO | $10,000 2,357 shares | - | |
| 59Moderate | Verrica Pharmaceuticals Inc. | David Zawitz Chief Operating Officer | $42k 10,000 shares | +91% | |
| 15Weak | VRCAsell Verrica Pharmaceuticals Inc. | Christopher G. Hayes CHIEF LEGAL OFFICER | $2,805 4,315 shares | -2% | |
| 41Moderate | VRCAbuy Verrica Pharmaceuticals Inc. | Perceptive Advisors LLC owner | $2.3M 321,616 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.